Therapeutic treatment for renal dysfunction

摘要

A method for treating renal dysfunctions is disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N, N'-1,1'-((2''-ethoxy)-3'''(O)-4'''-(N,N-dimethylamino)-butane)-bis-(3,3'-indolyl) ]-1(H)-pyrrole-2,5-dionehydrochloridesalt.